Effects of curcumin supplementation on homocysteine levels: a systematic review and meta-analysis of randomized controlled trials
Frontiers in Pharmacology · 16.07.2026 · 17
DOI: 10.3389/fphar.2026.1864151 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Frontiers in Pharmacology, online erschienen am 16.07.2026. Verfasst von Hong Cao und 9 weiteren Autor:innen. Beteiligte Einrichtung: Nutrition Department (Center for Clinical Evaluation of Functional Foods), Affiliated Hospital of Jiangnan University, Wuxi, China. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Homocysteine (Hcy) is an established cardiovascular risk factor, and dietary modulation via nutraceuticals represents a promising preventive strategy. Curcumin, a bioactive polyphenol from Curcuma longa L., exhibits pleiotropic biological activities; however, its capacity to reduce circulating Hcy remains uncertain.
Objectives
To systematically evaluate the effect of curcumin supplementation on Hcy levels.
Methods
Eight databases were searched from inception to November 2025 for RCTs investigating curcumin and Hcy outcomes. Risk of bias was assessed using Cochrane RoB 2.0. A random-effects model was applied.
Results
Three randomized controlled trials (RCT) with a total of 110 subjects were included in this study. Due to physiologically implausible Hcy values in one study (Rezaei 2024), the primary meta-analysis was restricted to two RCTs with interpretable data (Ghaffari 2017 and Campbell 2019). The results of Meta-analysis showed that compared with the control group, the pooled standardized mean difference SMD = −2.08, 95% confidence interval was −4.67 to 0.51, P = 0.116, there was no statistically significant difference between the two groups. There was a high degree of heterogeneity among the included studies (I 2 = 91.6%, P = 0.001). Risk of bias assessment (RoB 2.0) rated one study as low risk, one as some concerns, and one as high risk (selective reporting). Sensitivity analysis that included the study with implausible data (Rezaei 2024) gave a similar non-significant pooled estimate (SMD = −1.23, 95% CI −2.82 to 0.36, P = 0.13; I 2 = 91.9%).
Conclusion
Current RCT evidence does not support a statistically significant Hcy-lowering effect of curcumin. The overall certainty of evidence is very low due to small sample size, extreme heterogeneity, and risk of bias. Curcumin should not be recommended as a standalone intervention for lowering Hcy. Its potential role, if any, requires confirmation in well-powered trials using optimized, high-bioavailability formulations.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Nutrition Department (Center for Clinical Evaluation of Functional Foods), Affiliated Hospital of Jiangnan University, Wuxi, China.
- School of Biotechnology, Jiangnan University, Wuxi, China.
- Wuxi Medical College, Jiangnan University, Wuxi, China.
- Jiangsu Jicui Future Food Technology Research Institute Co., Ltd., Yixing, China.
- Endocrine Department, Jiangnan University Affiliated Hospital, Wuxi, China.
Zitieren
APA
Cao, H., Ning, W., Zhang, F., Zhang, X., Yan, J., Wang, Y., Sun, J., Liu, Y., Li, D., & Yang, J. (2026). Effects of curcumin supplementation on homocysteine levels: a systematic review and meta-analysis of randomized controlled trials. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1864151
Vancouver
Cao H, Ning W, Zhang F, Zhang X, Yan J, Wang Y, et al. Effects of curcumin supplementation on homocysteine levels: a systematic review and meta-analysis of randomized controlled trials. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1864151
BibTeX
@article{Cao2026,
author = {Cao, Hong and Ning, Wenrui and Zhang, Feng and Zhang, Xin and Yan, Jiai and Wang, Yingyu and Sun, Jing and Liu, Yiran and Li, Dan and Yang, Ju},
title = {Effects of curcumin supplementation on homocysteine levels: a systematic review and meta-analysis of randomized controlled trials},
journal = {Frontiers in Pharmacology},
year = {2026},
volume = {17},
doi = {10.3389/fphar.2026.1864151}
}
EUVIMED